Gastrointestinal Dysmotility on Aspiration Risk

Recruiting now · Phase 4

Conditions studied: Esophageal Motility Disorders, Gastric Motor Dysfunction, Aspiration Pneumonia, Gastro Esophageal Reflux

In brief

The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.

Key facts

Study ID
NCT05455359
Run by
Boston Children's Hospital
People needed
120
Starts
2025-02-13
Expected to finish
2027-05-31
Last updated by the study team
2026-08-03

Who can join

Age: 5 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.